Esperion Therapeutics Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
294
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
13
- Investments
-
3
Esperion Therapeutics General Information
Description
Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.
Contact Information
Website
www.esperion.comCorporate Office
- 3891 Ranchero Drive
- Suite 150
- Ann Arbor, MI 48108
- United States
Corporate Office
- 3891 Ranchero Drive
- Suite 150
- Ann Arbor, MI 48108
- United States
Esperion Therapeutics Timeline
Esperion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Esperion Therapeutics Comparisons
Industry
Financing
Details
Esperion Therapeutics Competitors (75)
One of Esperion Therapeutics’s 75 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Helsinn Healthcare | Corporation | Lugano, Switzerland | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Corcept Therapeutics | Formerly VC-backed | Redwood City, CA |
Esperion Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Esperion Therapeutics Patents
Esperion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226859-A1 | Methods of treating cholangiopathic disorders using macrocyclic inhibitors of atp citrate lyase | Pending | 23-Apr-2025 | ||
| WO-2026226855-A1 | Small molecule inhibitors of atp citrate lyase | Pending | 23-Apr-2025 | ||
| WO-2026226856-A1 | Small molecule inhibitors of atp citrate lyase | Pending | 23-Apr-2025 | ||
| WO-2026226862-A1 | Small molecule inhibitors of atp citrate lyase | Pending | 23-Apr-2025 | ||
| AU-2024369820-A1 | Macrocyclic inhibitors of atp citrate lyase | Pending | 01-Nov-2023 | A61P35/00 |
Esperion Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Esperion Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Esperion Therapeutics Acquisitions (3)
Esperion Therapeutics’s most recent deal was a Merger/Acquisition with RESQ Pharmaceutical for . The deal was made on 02-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RESQ Pharmaceutical | 02-Apr-2026 | Merger/Acquisition | Drug Discovery | ||
| Esperion Therapeutics (Acquired) | 28-Apr-2008 | Merger/Acquisition | Drug Discovery | ||
| Talaria Therapeutics | 05-Oct-2000 | Merger/Acquisition | Drug Discovery |
Esperion Therapeutics FAQs
-
When was Esperion Therapeutics founded?
Esperion Therapeutics was founded in 2008.
-
Where is Esperion Therapeutics headquartered?
Esperion Therapeutics is headquartered in Ann Arbor, MI.
-
What is the size of Esperion Therapeutics?
Esperion Therapeutics has 294 total employees.
-
What industry is Esperion Therapeutics in?
Esperion Therapeutics’s primary industry is Pharmaceuticals.
-
Is Esperion Therapeutics a private or public company?
Esperion Therapeutics is a Private company.
-
What is the current valuation of Esperion Therapeutics?
The current valuation of Esperion Therapeutics is .
-
What is Esperion Therapeutics’s current revenue?
The current revenue for Esperion Therapeutics is .
-
How much funding has Esperion Therapeutics raised over time?
Esperion Therapeutics has raised $836M.
-
Who are Esperion Therapeutics’s investors?
ARCHIMED has invested in Esperion Therapeutics.
-
Who are Esperion Therapeutics’s competitors?
Pfizer Pakistan, Pfizer (Vienna), Helsinn Healthcare, Evonile Pharma, and Corcept Therapeutics are some of the 75 competitors of Esperion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
